ArticleFrontiers in neurology2025
Factors influencing adherence to positive airway pressure therapy in stroke patients with obstructive sleep apnea: a cross-sectional study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A multilevel CPAP support strategy implemented within a large stroke clinical trial (sleep SMART).Frontiers in sleep · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Positive Airway Pressure (PAP) treatment is the recommended initial approach for moderately severe obstructive sleep apnea patients. Its efficacy is contingent upon patient compliance, yet compliance studies in combined stroke and obstructive sleep apnea (OSA) patients have demonstrated lower rates of compliance, and most of the influencing factors are unregulated. This study aimed to explore short-term respiratory therapy compliance status among stroke patients with obstructive sleep apnea and identify modifiable influencing factors to improve compliance and create personalized plans. Methods: This study was conducted among 254 stroke patients with OSA. Data were collected using standardized questionnaires, including the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and Self-Efficacy Measure for Sleep Apnea (SEMSA). Polysomnography (PSG) was used to assess objective sleep parameters. Logistic regression analysis was performed to identify predictors of PAP adherence. Results: The overall compliance rate of stroke patients with OSA was 27.2%, and self-efficacy in patients with stroke combined with OSA (perceived risk (OR = 2.23, 95% CI = 1.74 ~ 2.83), expected effect of treatment (OR = 1.23, 95% CI = 1.23 ~ 1.4), self-assessment (OR = 1.17, 95% CI = 1.06 ~ 1.30), total score on the Health Beliefs Scale (OR = 1.20, 95% CI = 1.13 ~ 1.26)), objective sleep condition (total sleep duration (OR = 1.00, 95% CI = 1.00 ~ 1.01), sleep efficiency (OR = 1.00, 95% CI = 1.00 ~ 1.04)) (OR = 1.01, 95% CI = 1.00 ~ 1.02), N1 phase duration (OR = 1.01, 95% CI = 1.00 ~ 1.01)), OSA severity (AHI (OR = 1.04, 95% CI = 1.02 ~ 1.06), and longest hypoventilation time (s) (OR = 1.02, 95% CI = 1.00 ~ 1.03), and oxygen desaturation ≥3 index (ODI) (OR = 1.03, 95% CI = 1.01 ~ 1.05) were the risk factors affecting their PAP treatment. Conclusion: Patients with stroke combined with OSA have poorer compliance to PAP treatment (27.2%) compared with the general population, and this compliance is closely related to self-efficacy, objective sleep, and the severity of OSA. In the future, we can combine with the Health Belief Models to formulate an individualized intervention plan based on patients' self-efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.